Assessment of dysmyelination with RAFFn MRI: application to murine MPS I

David Satzer1, Christina DiBartolomeo1, Michael M Ritchie1

  • 1Department of Neurosurgery, University of Minnesota, Minneapolis, Minnesota, United States of America.

Plos One
|February 14, 2015
PubMed

Insights

Type I mucopolysaccharidosis (MPS I) causes neurological issues and white matter abnormalities. A new MRI technique, RAFF5, detected subtle brain dysmyelination in MPS I mice, correlating with myelin density and explaining cognitive deficits.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Medical Imaging

Background:

  • Type I mucopolysaccharidosis (MPS I) is a genetic disorder affecting lysosomal function.
  • Neurological symptoms, including white matter abnormalities, are common in MPS I.
  • Current methods for assessing myelination in MPS I are limited.

Purpose of the Study:

  • To validate a novel MRI technique, RAFFn, for assessing myelination.
  • To investigate white matter integrity in MPS I mice using RAFF5.
  • To correlate MRI findings with histological myelin assessments.

Main Methods:

  • Validated RAFFn MRI technique in mice.
  • Compared RAFF5 relaxation times and histology between MPS I mice and heterozygotes.
  • Performed theoretical analysis using Bloch-McConnell equations.

Main Results:

  • RAFF5 relaxation time constants strongly correlated with myelin density (R2 = 0.68).
  • RAFF5 distinguished between myelinated and unmyelinated mouse models.
  • MPS I mice showed significantly increased RAFF5 relaxation times in the striatum and internal capsule, indicating subtle dysmyelination.

Conclusions:

  • RAFF5 is a sensitive MRI measure of myelination and dysmyelination.
  • MPS I mice exhibit subtle white matter dysmyelination, potentially due to lipid abnormalities.
  • These findings may explain neurological deficits observed in MPS I.

Related Concept Videos